Glenmark Pharma schedules Q1 FY27 earnings call on August 3, 2026

Board & Shareholder Meetings View source PDF

GLENMARK · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-1.8%1-day move

₹2242.10

prior close

₹2229.80

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.9-1.0-1.5-2.1-1.8-1.8-1.9-2.6——————

Up moveDown movePending

AI summary

Glenmark Pharmaceuticals has scheduled an earnings call on Monday, August 3, 2026, from 8:30 am to 9:30 am IST to discuss its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). The company has shared dial-in numbers for participants in India, USA, UK, Singapore, and Hong Kong. This is a routine intimation under SEBI disclosure rules filed ahead of the results announcement.

Likely market impact

Routine scheduling update. Watch for Q1 FY27 numbers and management commentary on growth outlook and guidance during the call.